Improved preparation of class I HLA tetramers and their use in detecting CMV-specific CTL

Journal of Immunological Methods

Volumn 312, Issue 1-2, 2006, Pages 148-156

  Ruan, Guang Ping ^a   Ma, Li ^a   Meng, Min Jie ^a   Zhu, Yong ^c   Chen, Ze Hong ^c   Lin, Ying ^b   Wu, Zheng Qiang ^b   He, Xiao Wei ^b   Wang, Ju Fang ^b   Wang, Xiao Ning ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c Time Biomedics Corporation Ltd   (China)

Author keywords

Class I HLA tetramers; CMV specific CTL; Detection; Preparation

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; TETRAMER;

ADOPTIVE TRANSFER; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; VIRUS DETECTION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ESCHERICHIA COLI; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INCLUSION BODIES; PEPTIDES; PHOSPHOPROTEINS; PROTEIN FOLDING; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS;

EID: 33646930366     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.03.002     Document Type: Article

References (19)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94
2. Aubert G., Hassan-Walker A.F., Madrigal J.A., Emery V.C., Morte C., Grace S., Koh M.B., Potter M., Prentice H.G., Dodi I.A., and Travers P.J. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J. Infect. Dis. 184 (2001) 955
3. Bachinsky M.M., Guillen D.E., Patel S.R., Singleton J., Chen C., Soltis D.A., and Tussey L.G. Mapping and binding analysis of peptides derived from the tumor-associated antigen surviving for eight HLA alleles. Cancer Immun. 5 (2005) 6
4. Bercovici N., Duffour M.T., Agrawal S., Salcedo M., and Abastado J.P. New methods for assessing T-cell responses. Clin. Diagn. Lab. Immunol. 7 (2000) 859
5. Cwynarski K., Ainsworth J., Cobbold M., Wagner S., Mahendra P., Apperley J., Goldman J., Craddock C., and Moss P.A. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97 (2001) 1232
6. *0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90 (1997) 1751
7. Garboczi D.N., Hung D.T., and Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3429
8. Gibson L., Piccinini G., Lilleri D., Revello M.G., Wang Z., Markel S., Diamond D.J., and Luzuriaga K. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J. Immunol. 172 (2004) 2256
9. Gratama J.W., and Cornelissen J.J. Diagnostic potential of tetramer-based monitoring of cytomegalovirus-specific CD8+ T lymphocytes in allogeneic stem cell transplantation. Clin. Immunol. 106 (2003) 29
10. Greten T.F., Korangy F., Neumann G., Wedemeyer H., Schlote K., Heller A., Scheffer S., Pardoll D.M., Garbe A.I., Schneck J.P., and Manns M.P. Peptide-b2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J. Immunol. Methods 271 (2002) 125
11. Kalergis A.M., Goyarts E.C., Palmieri E., Honda S., Zhang W., and Nathenson S.G. A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I. J. Immunol. Methods 234 (2000) 61
12. Komatsu H., Sierro S.V., Cuero A., and Klenerman P. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin. Exp. Immunol. 134 (2003) 9
13. Lopez-Labrador F.X., He X.S., Berenguer M., Cheung R.C., Wright T.L., and Greenberg H.B. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. J. Immunol. Methods 287 (2004) 91
14. McLaughlin-Taylor E., Pande H., Forman S.J., Tanamachi B., Li C.R., Zaia J.A., Greenberg P.D., and Riddell S.R. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43 (1994) 103
15. Sato Y., Sahara H., Tsukahara T., Kondo M., Hirohashi Y., Nabeta Y., Kawaguchi S., Ikeda H., Torigoe T., Ichimiya S., Tamura Y., Wada T., Yamashita T., Goto M., Takasu H., and Sato N. Improved generation of HLA class I/peptide tetramers. J. Immunol. Methods 271 (2002) 177
16. Tsai S.L., Lee T.H., Chien R.N., Liao S.K., Lin C.L., Kuo G.C., and Liaw Y.F. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment. J. Immunol. Methods 285 (2004) 71
17. Walter J.B., Garboczi D.N., Fan Q.R., Zhou X., Walker B.D., and Eisen H.N. A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors. J. Immunol. Methods 214 (1998) 41
18. Whiteside T.L. Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy. Clin. Diagn. Lab. Immunol. 7 (2000) 327
19. Wills M.R., Carmichael A.J., Mynard K., Jin X., Weekes M.P., Plachter B., and Sissons J.G. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70 (1996) 7569